SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+2.5%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$555M
AUM Growth
+$555M
(-6.7%)
Cap. Flow
-$47.6M
Cap. Flow
% of AUM
-8.58%
Top 10 Holdings %
Top 10 Hldgs %
62.94%
Holding
41
New
5
Increased
14
Reduced
11
Closed
11
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$14.6M |
| 2 |
Cardinal Health
CAH
|
$14.2M |
| 3 |
Universal Health Services
UHS
|
$10.3M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$9.32M |
| 5 |
Merck
MRK
|
$9.08M |
Top Sells
| 1 |
Biogen
BIIB
|
$21M |
| 2 |
Gilead Sciences
GILD
|
$19.2M |
| 3 |
Cigna
CI
|
$14.9M |
| 4 |
McKesson
MCK
|
$10.5M |
| 5 |
GSK
GSK
|
$9.69M |
Sector Composition
| 1 | Healthcare | 98.65% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Abbott
ABT
$231B
| $66.3M | 11.94% | 1,105,642 +25,800 | +2% | +$1.55M |
|
2
Boston Scientific
BSX
$156B
| $47.6M | 8.57% | 1,741,380 +40,500 | +2% | +$1.11M |
|
3
Baxter International
BAX
$12.7B
| $46.5M | 8.39% | 715,438 +21,000 | +3% | +$1.37M |
|
|
4
Merck
MRK
$210B
| $39.5M | 7.12% | 725,200 +166,700 | +30% | +$9.08M |
|
5
Revvity
RVTY
$10.5B
| $28.6M | 5.16% | 378,206 -62,602 | -14% | -$4.74M |
|
6
AstraZeneca
AZN
$248B
| $28.2M | 5.08% | 806,035 -90,736 | -10% | -$3.17M |
|
|
SHPG
7
DELISTED
Shire pic
SHPG
| $24.6M | 4.44% | 164,975 +97,900 | +146% | +$14.6M |
|
8
Bio-Rad Laboratories Class A
BIO
$8.06B
| $23.6M | 4.25% | 94,240 -800 | -0.8% | -$200K |
|
9
Bristol-Myers Squibb
BMY
$96B
| $22.9M | 4.13% | 362,006 -23,000 | -6% | -$1.45M |
|
10
Integra LifeSciences
IART
$1.18B
| $21.4M | 3.86% | 386,966 -119,664 | -24% | -$6.62M |
|
11
Eli Lilly
LLY
$657B
| $19.5M | 3.52% | 252,514 +99,100 | +65% | +$7.67M |
|
|
NUVA
12
DELISTED
NuVasive, Inc.
NUVA
| $19.4M | 3.5% | 371,997 +111,797 | +43% | +$5.84M |
|
13
Elevance Health
ELV
$71.8B
| $18.9M | 3.4% | 85,910 -35,400 | -29% | -$7.78M |
|
14
Ironwood Pharmaceuticals
IRWD
$214M
| $17.3M | 3.12% | 1,121,135 -67,418 | -6% | -$1.04M |
|
|
15
Cardinal Health
CAH
$35.5B
| $14.2M | 2.56% | +226,263 | New | +$14.2M |
|
16
Labcorp
LH
$23.1B
| $13.7M | 2.46% | 84,400 +4,400 | +6% | +$712K |
|
17
Tenet Healthcare
THC
$16.3B
| $13M | 2.33% | 534,021 +68,400 | +15% | +$1.66M |
|
|
18
Ionis Pharmaceuticals
IONS
$6.8B
| $12.1M | 2.17% | 273,500 +211,400 | +340% | +$9.32M |
|
19
Perrigo
PRGO
$3.27B
| $11.5M | 2.07% | 137,840 -111,700 | -45% | -$9.31M |
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $10.8M | 1.95% | 64,300 +1,700 | +3% | +$286K |
|
|
21
Universal Health Services
UHS
$11.6B
| $10.3M | 1.86% | +86,973 | New | +$10.3M |
|
|
22
Gilead Sciences
GILD
$140B
| $7.8M | 1.41% | 103,500 -254,390 | -71% | -$19.2M |
|
23
Lexicon Pharmaceuticals
LXRX
$400M
| $7.32M | 1.32% | 854,592 +17,400 | +2% | +$149K |
|
|
PDCO
24
DELISTED
Patterson Companies, Inc.
PDCO
| $6.94M | 1.25% | 312,232 +9,100 | +3% | +$202K |
|
|
CLVS
25
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.54M | 1.18% | 123,892 -27,100 | -18% | -$1.43M |
|